Technical Advisory Council on Drugs

No doctor’s prescription needed for Refresh Tears: DTAB

by

No doctor’s prescription needed for Refresh Tears: DTAB We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To find out more, see our Cookie Policy and Cookie Settings.Ok

Rejecting Abbott’s proposal DTAB regulates Zolpidem which continues to be a Schedule H1 drug

by

Rejecting Abbott’s proposal DTAB regulates Zolpidem which continues to be a Schedule H1 drug We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To find out more, see our Cookie Policy and Cookie Settings.Ok